Active Ingredient History
Grape seed extract is an industrial derivative of whole grape seeds. The extract contains proanthocyanidins. Grape seed extract quality is measured by the content of procyanidins which are formed from proanthocyanidins. Generally, grape seed extract quality contains 95% procyanidins, but potency varies among products. Eating foods or beverages high in procyanidin results in an astringent sensation in the mouth. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Alzheimer Disease (Phase 2)
Atherosclerosis (Phase 2)
Blood Pressure (Phase 3)
Cardiovascular Diseases (Phase 4)
Chronic Periodontitis (Phase 2)
Cognitive Dysfunction (Phase 2)
Colonic Neoplasms (Phase 1)
COVID-19 (Phase 1/Phase 2)
Dental Caries (Phase 1)
Dental Plaque (Phase 3)
Diabetes Mellitus, Type 2 (Phase 4)
Diabetic Retinopathy (Phase 4)
Fatigue (Early Phase 1)
Glaucoma, Open-Angle (Phase 1)
Glucose Metabolism Disorders (Phase 4)
Gulf War (Phase 1/Phase 2)
Head and Neck Neoplasms (Phase 1)
Healthy Volunteers (Phase 2)
Heart Disease Risk Factors (Phase 3)
Heart Diseases (Phase 1)
Heart Failure, Diastolic (Phase 1)
Hyperlipidemias (Phase 2/Phase 3)
Hypertension (Phase 1)
Inflammation (Phase 2/Phase 3)
Insulin Resistance (Phase 4)
Irritable Bowel Syndrome (Phase 4)
Lipid Metabolism Disorders (Phase 4)
Lipoproteins, LDL (Phase 1)
Neoplasms (Phase 1)
Non-alcoholic Fatty Liver Disease (Early Phase 1)
Osteoarthritis, Knee (Phase 3)
Osteoporosis (Phase 2)
Oxidative Stress (Phase 2/Phase 3)
Parkinson Disease (Phase 1)
Prostatic Neoplasms (Phase 3)
Stomatitis (Phase 1)
Urinary Tract Infections (Phase 4)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue